|
Welcome to our new website |
|
Friday, 29 January 2010 13:19 |
We hope you like the new layout and that you will like the new features which will be added over the coming weeks. (Comment option is now available in news sections. Click 'READ MORE' to find the feature if it's not displayed.) Many more weblinks to international AND national websites, blogs and forums have been added to our database in our efforts to provide people from around the world with support and reliable sources of information.
Our focus is going to be on making information available in many languages. If you are fluent in English and have another language as your native, please contact us and become part of the translaton team. Translating information is an unique way to help increase awareness of recent biomedical research, not only to patients, but also to the general publc. There are an estimated 25 to 28 million people affected, imagine what would happen if we could reach the 20 million outside the US/UK....
Another project at Diagnose Support is the attempt to bring Advocates together and benefit from the synergy and efficiancy of working together. If you are an advocate or if you host a website, forum, facebook group, please contact us and become part of our Global Advocate Team.
Of course we will keep you updated on the latest XMRV news, the implications, national developments, research and testing. But we are also closely monitoring the effect of new biomedical research on the way patients wth M.E./C.F.S, Fm and other Neuro-Immune/Neuro Endocrine Immune related disorders are treated by their community and healthcare providers, and how governments will react now that is clear, without a doubt, that we are speaking about phsyiological processes involved in these illnesses, which can be treated.
Please stay tuned to our updates and check back regularly. If you feel you have information whe should publish, feel free to contact us.
We now make it a habit of mentioning the source at the top of the articles. It says "Written by...." If that is an organization or other patient platform, it is most likely a reposted item, for translation purposes. The link to that website is always at the bottom of the full view article, both the original and the translated one.
|